science wire

Diabetes affects about half a billion people worldwide, most of them in lowand middle-income countries.

The World Health Organization (WHO) has designated Swiss TPH as the WHO Collaborating Centre for Verbal Autopsy.

Co-authored by over 30 international experts, a new policy brief has been published which recommends leveraging Switzerland's scientific and diplomatic role in One Health.

The SOPHYA study of the Swiss Tropical and Public Health Institute (Swiss TPH) investigated the physical activity and sports behaviour of children and adolescents throughout Switzerland over a period of five years. Physical activity did not decrease during the COVID 19 pandemic. Results show that the living environment and physical activity of the parents have a significant influence on physical activity behaviour during childhood and thus have a long-term impact on the health of children and later adults.

Climate change is an imminent threat to human health and well-being and to our planet. Urgent action is needed in order to reduce climate risks and secure a liveable future.

Swiss TPH has been awarded four out of six new research grants from the Principal Investigator Initiative of the Botnar Research Centre for Child Health (BRCCH).

There is very limited data on the incidence and prevalence of noma, which hinders better management and treatment of this devastating disease that mainly affects young and malnourished children in very poor communities.

The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.

Global health decision-makers use frameworks to support them with creating strategies to meet global elimination targets for diseases, such as sleeping sickness. In a recent study by Swiss TPH, researchers proposed a new health economic framework that uses a unique combination of uncertainty, cost-effectiveness and elimination to support the World Health Organizations (WHO) goal of eliminating sleeping sickness by 2030.

TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières with partners including Swiss TPH, has found that a new all-oral treatment regimen for rifampicin-resistant tuberculosis (RR-TB) is safer and more effective than the current accepted standard of care.

Yesterday, the World Health Organization (WHO) recommended the widespread use of the malaria vaccine RTS,S/AS01, debuting a tool that could save the lives of tens of thousands of children in sub-Saharan Africa each year.

Today, the World Health Organization launched their new Global Air Quality Guidelines, which aims to protect the health of populations by reducing key air pollutants.

Together with the Bill and Melinda Gates Foundation, Swiss TPH has launched a new project bringing together research & development and implementation specialists, modellers and global-health experts to shape the next-generation of medical interventions for malaria prevention.

The JeuneS3 (Santé, Sécurité, Sexualité) programme, which focused on improving adolescent and youth sexual and reproductive health in four Francophone African countries, has come to a close after four successful years.

The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited.

In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population. Therefore, seroprevalance has markedly increased since autumn of last year. Furthermore, the COVCO-Basel study by the Swiss Tropical and Public Health Institute (Swiss TPH) is now publishing preliminary results regarding the effects that the pandemic and the measures implemented to contain it are having on the well-being and lifestyles of the population for the first time.

In the cantons of Basel-Stadt and Basel-Landschaft, antibodies against SARS-CoV-2 have been detected in approximately 21% of the adult population.

Over the past two decades, substantial progress has been made in reducing the global burden of malaria through vector control interventions and improved access to diagnosis and treatment.

We are deeply saddened to learn of the unexpected passing of Dr. Reinhard Glück. He passed away unexpectedly on Sunday, 19 April, 2021, shortly before reaching the age of 70.

Bad news for allergy sufferers: The rising temperatures over the past three decades have impacted the onset, duration and intensity of the pollen season in Switzerland. These are the results of a study by the Swiss Tropical and Public Health Institute (Swiss TPH) in collaboration with the Federal Office of Meteorology and Climatology (MeteoSwiss).

A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and that more patient data was extremely unlikely to change the trial's outcome.

Swiss TPH and the European Chapter of the International Society of Environmental Epidemiology (ISEE) hosted a virtual symposium for young scientists in the field of environmental epidemiology from 18 to 19 February 2021.

A new joint initiative from the Botnar Research Centre for Child Health and the European and Developing Countries Clinical Trials Partnership will support three COVID-19-related projects in lowand mi

The unprecedented progress made in global health over the past 20 years is being threatened by the COVID-19 pandemic.

The coronavirus is not only a risk for our physical health, but also affects our mental health and emotional well-being.

Strong and resilient supply chains ensure the provision of quality health products and vaccines to patients, making them a central component of health systems.